Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

DERM stock hub

Journey Medical Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DERMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

138.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DERM

In the news

Latest news · DERM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E69.9

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-44

P25 -105.6P50 -46.5P75 -3.1

ROIC-27.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DERM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001867066
Company name	Journey Medical Corporation
Country	United States
Country code	US
Cusip	48115J109
Employees	58
Employees Change	17%
Employees Change Percent	41.46
Enterprise value	$139.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2021-11-12
Isin	US48115J1097
Last refreshed	2026-05-10
Market cap	$138.6M
Market cap category	Micro-Cap
Price	$5.07
Price currency	USD
Rev Per Employee	1,066,517.24x
Sector	Healthcare
Sic	2834
Symbol	DERM
Website	https://journeymedicalcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.25%
EV Sales Forward	1.62x
EV/Sales	2.26x
FCF yield	-8.98%
Forward P/E	69.93x
P/B ratio	4.32x
P/S ratio	2.24x
PS Forward	1.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.21%
EBITDA Margin	-6.33%
Gross margin	66.17%
Gross Profit	$40.9M
Gross Profit Growth	16.11%
Gross Profit Growth Q	19%
Gross Profit Growth3 Y	-1.55%
Gross Profit Growth5 Y	6.46%
Net Income	$-11.4M
Net Income Growth Years	1%
Pretax Margin	-18.38%
Profit Margin	-18.48%
Profit Per Employee	$-197,086
ROA	-5.84
Roa5y	-9.75
ROCE	-14.3
ROE	-44.03
Roe5y	-81.16
ROIC	-27.51
Roic5y	-133.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-27.07%
Cagr3y	48.43%
EPS Growth Years	1
Revenue Growth	10.2x
Revenue Growth Q	18.05x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-5.66x
Revenue Growth5 Y	6.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.71
Assets	$94.6M
Cash	$24.1M
Current Assets	$66.9M
Current Liabilities	$37.4M
Debt	$25.4M
Debt Equity	$0.8
Equity	$31.9M
Interest Coverage	-2.21
Liabilities	$62.7M
Long Term Assets	$27.7M
Long Term Liabilities	$25.3M
Net Cash	$-1.3M
Net Cash By Market Cap	$-0.94
Net Debt Equity	$0.04
Tangible Book Value	$4.2M
Tangible Book Value Per Share	$0.16
WACC	10.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.79
Inventory Turnover	1.74
Net Working Capital	$5.4M
Quick ratio	1.44
Working Capital	$29.4M
Working Capital Turnover	$2.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.9%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-27.05%
200-day SMA	7.32
3Y total return	227.12%
50-day SMA	6
50-day SMA vs 200-day SMA	50under200
All Time High	10.2
All Time High Change	-50.29%
All Time High Date	2021-11-12
All Time Low	1.02
All Time Low Change	397.06%
All Time Low Date	2023-05-18
ATR	0.32
Beta	1.04
Beta1y	1.99
Beta2y	0.48
Ch YTD	-34.24
High	5.1
High52	9.56
High52 Date	2026-01-23
High52ch	-46.94%
Low	4.84
Low52	4.31
Low52 Date	2026-03-30
Low52ch	17.63%
Ma50ch	-15.51%
Price vs 200-day SMA	-30.7%
RSI	41.85
RSI Monthly	43.64
RSI Weekly	35.92
Sharpe ratio	-0.21x
Sortino ratio	-0.19
Total Return	-19.9%
Tr YTD	-34.24
Tr1m	2.42%
Tr1w	-2.31%
Tr3m	-39.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	15,396,536x
Earnings Revenue Estimate Growth	17.18x
Operating Income	$-8.2M
Operating margin	-13.21
Price target	$12.67
Price Target Change	$150

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,623,783%
Float Percent	53.51%
Net Borrowing	-625,000
Shares Insiders	12.24%
Shares Institutions	43.78%
Shares Out	27,330,696
Shares Qo Q	8.6%
Shares Yo Y	19.9%
Short Float	25.43%
Short Ratio	10.4
Short Shares	13.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.7M
Average Volume	166,930.95x
Bv Per Share	1.17
Ch1m	2.42
Ch1w	-2.31
Ch1y	-27.05
Ch3m	-39.28
Ch3y	227.1
Ch6m	-44.35
Change	1.4%
Change From Open	1.81
Close	5
Days Gap	-0.4
Depreciation Amortization	4,258,000
Dollar Volume	510,285.4
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-8.2M
EBITDA	$-3.9M
EPS	$-0.47
F Score	2
FCF	$-12.4M
FCF EV Yield	-8.89x
FCF Per Share	$-0.46
Financing CF	16,226,000
Fiscal Year End	December
Founded	2,014
Income Tax	$60,000
Ipr	-49.3
Iprfo	-41.72
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma150	7.33
Ma150ch	-30.8%
Ma20	5.16
Ma20ch	-1.74%
Net CF	3,785,000
Next Earnings Date	2026-05-13
Open	4.98
Optionable	Yes
Position In Range	88.46
Ppne	111,000
Price Date	2026-05-08
Ptbv Ratio	32.63
Relative Volume	0.6x
Revenue	61,858,000x
SBC By Revenue	10.17x
Share Based Comp	6,288,000
Tax By Revenue	0.1x
Tr6m	-44.35%
Us State	Arizona
Volume	100,648
Z Score	0.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DERM pay a dividend?

Capital-return profile for this ticker.

Performance

DERM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DERM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.8%

Float: +53.5% of shares outstanding

Insider ownership

+12.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DERM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.9

Neutral momentum band

Price vs 200-day MA

-30.7%

50/200-day relationship not available

Beta (5Y)

1.04

Moves roughly with the market

Sharpe ratio

-0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About DERM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DERM stock rating?

Journey Medical Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DERM analysis?

The full report lives at /stocks/DERM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DERM?

The latest report frames DERM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DERM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.